Tilray | TRLY - Los Gastos Financieros De La Deuda

Precio De Mercado
9.23
Cambio Diario
-0.23 -2.43%
Mensual
-3.75%
Anual
1,237.68%
Q2 Expectativa
9.04




Los Gastos Financieros De La Deuda Cambio Fecha
Akebia Therapeutics 4.83M 359.32M 2025-12
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aurora Cannabis CAD 2.11M 116K 2025-12
Avita Medical AUD 1.25M 100K 2025-06
Canopy Growth CAD 7.34M 1.46M 2025-12
Cronos Group USD 0 7K 2024-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 30M 2025-12
Ionis Pharmaceuticals USD 18M 0 2025-12
IQVIA Holdings USD 193M 4M 2025-12
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Moderna USD 12.14B 12.13B 2025-09
Organigram Holdings CAD 179K 127K 2025-03
Organon & Co USD 128M 3M 2025-09
Revvity USD 23.51M 742K 2025-12
Tectonic Therapeutic USD 12K 276.99M 2025-12
Tilray USD 6.7M 2.73M 2025-06
Viatris USD 119.6M 0 2025-12
Xeris Pharmaceuticals USD 7.15M 115K 2025-12
Zealand Pharma A/S 7.07M 74K 2025-12